BNB Plus Corp. splits its revenue into 10 lines in its filings. The largest line in fiscal 2025, which ended Sep 30, 2025 was Supply Chain at $1.1 million, 54% of the total.
USD in millions. The percent under a figure is the change from the year before.
| Line |
FY 2026
Jun 30, 2026
|
FY 2025
Sep 30, 2025
|
FY 2024
Sep 30, 2024
|
FY 2023
Sep 30, 2023
|
FY 2022
Sep 30, 2022
|
FY 2021
Sep 30, 2021
|
FY 2020
Sep 30, 2020
|
FY 2019
Sep 30, 2019
|
FY 2018
Sep 30, 2018
|
FY 2017
Sep 30, 2017
|
FY 2016
Sep 30, 2016
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
2
|
2
|
2
|
13
|
18
|
9
|
2
|
5
|
4
|
5
|
4
|
| Clinical Laboratory Service Revenues |
—
|
—
|
—
|
—
|
—
|
5
+6082.0%
share 53.1%
|
0
share 4.0%
|
—
|
—
|
—
|
—
|
| Clinical Laboratory Testing Services |
—
|
—
|
—
|
—
|
—
|
5
+6082.0%
share 53.1%
|
0
share 4.0%
|
—
|
—
|
—
|
—
|
| Diagnostic Kits |
—
|
—
|
—
|
—
|
—
|
2
share 21.8%
|
—
|
—
|
—
|
—
|
—
|
| Clinical Laboratory Testing Services Over Time |
—
|
—
|
1
-63.7%
share 60.8%
|
4
-31.0%
share 26.5%
|
5
share 28.2%
|
—
|
—
|
—
|
—
|
—
|
—
|
| Supply Chain |
—
|
1
-5.0%
share 53.8%
|
1
+46.0%
share 57.2%
|
1
-6.7%
share 6.2%
|
1
-11.6%
share 4.9%
|
1
+2500.6%
share 11.1%
|
0
share 2.0%
|
—
|
—
|
—
|
—
|
| Mdx Test Kits And Supplies |
—
|
—
|
—
|
—
|
1
share 3.5%
|
—
|
—
|
—
|
—
|
—
|
—
|
| Large Scale Dna Production |
—
|
1
+4.8%
share 28.7%
|
1
-10.6%
share 27.6%
|
1
share 4.9%
|
—
|
—
|
0
share 14.6%
|
—
|
—
|
—
|
—
|
| Research And Development Services |
—
|
0
+20.7%
share 17.6%
|
0
-26.2%
share 14.7%
|
0
-28.8%
share 3.2%
|
1
-26.0%
share 3.3%
|
1
-29.1%
share 8.9%
|
1
share 58.4%
|
—
|
—
|
—
|
—
|
| Clinical Laboratory Testing Services Point In Time |
—
|
—
|
0
-99.6%
share 1.5%
|
8
-26.8%
share 57.0%
|
10
share 57.2%
|
—
|
—
|
—
|
—
|
—
|
—
|
| Asset Marking |
—
|
—
|
0
-97.0%
share 0.4%
|
0
-41.7%
share 2.3%
|
1
+16.6%
share 2.9%
|
0
+13.2%
share 5.1%
|
0
share 21.0%
|
—
|
—
|
—
|
—
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Finance Services (SIC 6199)
- Listed as
- BNBX (OTC)
- Fiscal year ends
- September 30
- Incorporated in
- DE
- Headquarters
- Stony Brook, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 744452
- Former names
- APPLIED DNA SCIENCES INC (until Nov 10, 2025); PROHEALTH MEDICAL TECHNOLOGIES INC (until Dec 18, 2002); DCC ACQUISITION CORP (until May 4, 2001); DATALINK CAPITAL CORP/TX/ (until Feb 8, 1999)
Other Finance Services companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.